Atara Biotherapeutics, Inc.
Long
Mis à jour

ATRA -long- catalyst play

265
developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).

This is not a financial advice!

Upcoming catalysts 06/30/2024 and 06/30/2025

Block buys recently and passive stakes

Rel. Vol. on 03/08/2024 at 4.32

We need to stay in a bullish overal sentiment of the market. If we see a corretion, this play might doesn't work.

Keep an eye on 1.0 / 1.2 / 1.4 levels, needs to get broken for a further upmove. You can take partial profits at these levels if u want to lock in gains.

SL under 0.5 (very tight)

TPs approx. 2.0 maybe even 5.7

Most info on the chart.

Trade carefully!
Note
Atara Biotherapeutics, Inc. Passive Stake (FormSC13G)
Trade fermée: ordre d’arrêt atteint

Clause de non-responsabilité

Les informations et les publications ne sont pas destinées à être, et ne constituent pas, des conseils ou des recommandations en matière de finance, d'investissement, de trading ou d'autres types de conseils fournis ou approuvés par TradingView. Pour en savoir plus, consultez les Conditions d'utilisation.